Kinnari Patel, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 767 shares at $6.45 ($5K) on 2025-05-20, disclosed to the SEC on 2025-05-22.
Open-market sale of $5k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |
| RCKT | SELL | 2024-08-20 | $148K | — | Filing → |